9 commercial payer policies list Q9991. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
9 policies from 7 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of Q9991 |
|---|---|---|
| Buprenorphine (Brixadi & Sublocade) | Oct 1, 2026 | Covered |
| Buprenorphine (Brixadi & Sublocade) – Community Plan Medical Benefit Drug Policy | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Buprenorphine (Brixadi & Sublocade) – Individual Exchange Medical Benefit Drug Policy |
| Not recorded |
| Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q9991 |
|---|---|---|
| Extended-Release Injectable (Sublocade) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q9991 |
|---|---|---|
| Buprenorphine Injection (Sublocade, Brixadi); CP.PHAR.289 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q9991 |
|---|---|---|
| Probuphine (Buprenorphine) Implant for Subdermal Administration and Sublocade (Buprenorphine Extended-Release) Injection for Subcutaneous Use | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q9991 |
|---|---|---|
| Sublocade (buprenorphine extendedrelease) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q9991 |
|---|---|---|
| Buprenorphine (Brixadi & Sublocade) | Oct 1, 2026 | Covered |
| Policy | Effective | Status of Q9991 |
|---|---|---|
| Buprenorphine (Brixadi & Sublocade) | Oct 1, 2026 | Covered |